CSRxP Applauds Bipartisan Bill To Strengthen Drug Pricing Transparency
May 14, 2019
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today… Read More
© 2025 CSRXP- All Rights Reserved
Press Release
CSRxP Study Confirms: Big Pharma Invests Boldly in Profits and Advertising — Not R&D
May 14, 2019
Analysis Finds Industry Spending on Advertising, Overhead and Profits More… Read More
CSRxP Praises FDA For Finalizing Guidance On Interchangeable Biologics
May 10, 2019
Clearer Guidelines Will Increase Choice and Help Lower Prices Washington… Read More
CSRxP: Congress Takes First Step On Drug Pricing, Now Lawmakers Must Deliver
May 8, 2019
Encourages House Leaders To Keep The Momentum Going Following Passage Of First… Read More
CSRxP Urges House Lawmakers to Pass First Drug Pricing Bills of the Year
May 8, 2019
Vote On Orange And Purple Book Bills Should Mark Beginning Of A Series Of… Read More
CSRxP Praises Administration For Implementing Direct-To-Consumer Advertising Rule
May 8, 2019
Greater List Price Transparency Will Help Hold Big Pharma Accountable … Read More
CSRxP: Senate Judiciary Lawmakers Grill Big Pharma, Demonstrate Bipartisan Commitment To Action
May 7, 2019
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today… Read More
CSRxP Welcomes Senate Scrutiny Of Big Pharma’s Patent Abuse
May 6, 2019
Encourages Judiciary Committee To Hold Drug Makers Accountable… Read More
CBO Confirms: Rebate Rule Comes At Tremendous Cost to Seniors And Taxpayers
May 2, 2019
Nonpartisan Analysis Projects HHS Proposal A $187 Billion Budget-Buster That… Read More
CSRxP Applauds Advancement Of Bipartisan CREATES Act
Apr 30, 2019
Praises Lawmakers For Commitment To Delivering Relief For Patients Washington,… Read More
CSRxP Applauds Continued Drug Price Activity & Momentum On Capitol Hill
Apr 29, 2019
Encourages House Judiciary Committee To Advance Bipartisan CREATES Act… Read More
Big Pharma’s Record Spending On Lobbying Won’t Slow Bipartisan Momentum On Drug Prices
Apr 23, 2019
Filings Show Drug Makers Spent Nearly $10 Million on Lobbying in Q1 2019 –… Read More